BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14752080)

  • 1. Unusual lymphoma manifestations: case 3. CD8+ T-cell prolymphocytic leukemia.
    Nakajima H; Oki M; Ando K
    J Clin Oncol; 2004 Feb; 22(3):560-2. PubMed ID: 14752080
    [No Abstract]   [Full Text] [Related]  

  • 2. Small cell variant of T-cell prolymphocytic leukemia exhibiting suppressor phenotype.
    Thorat KB; Gujral S; Kumar A; Nair CN
    Leuk Lymphoma; 2006 Aug; 47(8):1711-3. PubMed ID: 16966296
    [No Abstract]   [Full Text] [Related]  

  • 3. Seropositive polyarthritis and skin manifestations in T-prolymphocytic leukemia/Sezary cell leukemia variant.
    Dybjer A; Hellquist L; Johansson B; Rydgren L; Billström R
    Leuk Lymphoma; 2000 Apr; 37(3-4):437-40. PubMed ID: 10752996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Remission in T-cell prolymphocytic leukemia during the FMC treatment course].
    Valiev TT; Vinogradova IuE; Chernova NG; Mar'in DS; Volkova IaK; Petrova VI; Bulanov AIu; Kalinin NN; Semenova EA; Gretsov EM; Kravchenko SK; Kremenetskaia AM; Vorob'ev AI
    Ter Arkh; 2006; 78(7):87-90. PubMed ID: 16944758
    [No Abstract]   [Full Text] [Related]  

  • 5. A new case of Sézary cell leukemia: a morphological variant of prolymphocytic leukemia.
    Pérez-Vila Mf; Espinet B; Solé F; Pedro C; Woessner S; Florensa L
    Haematologica; 2000 Jul; 85(7):775-6. PubMed ID: 10897140
    [No Abstract]   [Full Text] [Related]  

  • 6. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype.
    Sugimoto T; Imoto S; Matsuo Y; Kojima K; Yasukawa M; Murayama T; Kohfuku J; Mizuno I; Yakushijin K; Sada A; Nishimura R; Koizumi T
    Ann Hematol; 2001 Dec; 80(12):749-51. PubMed ID: 11797117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjunctival involvement with T-cell prolymphocytic leukemia: report of a case and review of the literature.
    Lee SS; Robinson MR; Morris JC; Mirtsching BC; Shen D; Chan CC
    Surv Ophthalmol; 2004; 49(5):525-36. PubMed ID: 15325197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are activation markers (CD25, CD38 and CD103) predictive of sensitivity to purine analogues in patients with T-cell prolymphocytic leukemia and other lymphoproliferative disorders?
    Delgado J; Bustos JG; Jimenez MC; Quevedo E; Hernandez-Navarro F
    Leuk Lymphoma; 2002 Dec; 43(12):2331-4. PubMed ID: 12613520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell prolymphocytic leukemia involving extramedullary sites.
    Valbuena JR; Herling M; Admirand JH; Padula A; Jones D; Medeiros LJ
    Am J Clin Pathol; 2005 Mar; 123(3):456-64. PubMed ID: 15716243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prolymphocytic leukemia].
    Jantunen E; Lahtinen R
    Duodecim; 1992; 108(10):955-9. PubMed ID: 1366274
    [No Abstract]   [Full Text] [Related]  

  • 11. [The prolymphocytic-lymphocytic leukemization of B-cell lymphosarcomas].
    Osmanov DSh; Kruglova GV; Frenkel' MA; Tupitsin NN; Probatova NA; Kondrat'eva TT; Sholokhova EN; Finogenova IA; Dvoretskiĭ VV
    Ter Arkh; 1996; 68(7):42-8. PubMed ID: 8928071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perforin-positive leukemic cell infiltration in the aortic tissue of a patient with T-cell prolymphocytic leukemia.
    Seko Y; Azuma M; Yagita H; Okumura K; Yazaki Y
    Int Angiol; 1996 Sep; 15(3):245-8. PubMed ID: 8971584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia/lymphoma, and Sézary syndrome.
    Foucar K
    Am J Clin Pathol; 2007 Apr; 127(4):496-510. PubMed ID: 17369126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolymphocytic leukemia or prolymphocytic transformation of mantle cell lymphoma.
    Veillon DM; Nordberg ML; Glass J; Sattar T; Cotelingam JD
    Am J Clin Pathol; 2001 Nov; 116(5):781-2. PubMed ID: 11710698
    [No Abstract]   [Full Text] [Related]  

  • 15. [The clinical and laboratory characteristics of mature (postthymic) T-cell malignant neoplasms].
    Matutes E; Catovsky D
    Gematol Transfuziol; 1993 May; 38(5):3-6. PubMed ID: 8034169
    [No Abstract]   [Full Text] [Related]  

  • 16. Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia?
    Pawson R; Matutes E; Brito-Babapulle V; Maljaie H; Hedges M; Mercieca J; Dyer M; Catovsky D
    Leukemia; 1997 Jul; 11(7):1009-13. PubMed ID: 9204983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined immunophenotyping and karyotyping in peripheral T cell lymphomas demonstrating different clonal and nonclonal chromosome aberrations in T helper cells.
    Schlegelberger B; Weber-Matthiesen K; Sterry W; Bartels H; Sonnen R; Maschmeyer G; Feller AC; Grote W
    Leuk Lymphoma; 1994 Sep; 15(1-2):113-25. PubMed ID: 7858488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell prolymphocytic leukemia with hemorrhagic gastrointestinal involvement and a new chromosomal abnormality.
    Toyota S; Nakamura N; Dan K
    Int J Hematol; 2002 Apr; 75(3):314-7. PubMed ID: 11999363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytology of chronic lymphocytic leukemias.
    Castoldi GL; Lanza F; Tomasi P; Cuneo A
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():144-8. PubMed ID: 2785423
    [No Abstract]   [Full Text] [Related]  

  • 20. Small cell variant of T-cell prolymphocytic leukemia with a gammadelta immunophenotype.
    Toyota S; Nakamura N; Dan K
    Int J Hematol; 2005 Jan; 81(1):66-8. PubMed ID: 15717692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.